GG #14
A lesser-known sibling in the GG (Gorilla Glue) family with sparse verifiable data and heavy marketing folklore.
GG #14 is marketed as another 'phenotype' in the GG line that produced GG4, but unlike GG4 there is almost no independent documentation of its chemistry, lineage, or effects. Most claims you'll read online are recycled from GG4 marketing copy. Treat vendor THC percentages, terpene charts, and effect lists as sales language, not data. If you like it, great — just don't assume you know what's in it.
Overview
GG #14 is sold as one of the numbered phenotypes selected during the breeding work that produced the well-known GG4 (originally 'Gorilla Glue #4') by GG Strains. GG4 itself is documented: it came from a Chem's Sister × Sour Dubb × Chocolate Diesel cross by breeders Josey Wales and Lone Watie, and the '#4' referred to a specific selected pheno [1][2]. GG #14 is presented in seed catalogs and dispensary menus as a sibling selection from the same or related crosses, but unlike GG4 it has no independent breeder documentation, court record, or lab dataset behind it No data. In practice, buyers should assume 'GG #14' on a menu could refer to several unrelated genetic lines.
Chemistry: cannabinoids and terpenes
There is no published, independent chemical characterization of GG #14 specifically. Dispensary listings commonly report THC in the high teens to mid-20s and negligible CBD, which is unremarkable for modern high-THC hybrids Weak / limited. Terpene profiles claimed by vendors typically mirror those attributed to GG4 — high beta-caryophyllene, myrcene, and limonene — but this appears to be copy-paste from GG4 marketing rather than measured data No data.
A general caution: single-sample THC and terpene numbers from cannabis dispensary labels are known to be inconsistent and often inflated compared to blinded testing [3]. Do not treat a menu percentage as a stable property of the cultivar.
Reported effects
Effect descriptions for GG #14 (heavy body relaxation, couch-lock, euphoria, appetite stimulation) come from user reviews and vendor descriptions, not clinical studies Anecdote. There is no strain-specific clinical trial evidence for GG #14 — or, for that matter, for essentially any named cannabis cultivar [4].
The common shorthand that 'indica-leaning' hybrids reliably produce sedation is not supported by chemotaxonomic evidence. Studies comparing 'indica' and 'sativa' labels to actual chemical composition find the labels are poor predictors of either genetics or effects [5] Strong evidence. Whatever GG #14 does for you is more likely a function of its actual cannabinoid and terpene load, your dose, your tolerance, and setting than of the name on the jar.
Lineage and naming disputes
The GG family name itself has legal history: GG Strains settled a trademark dispute with the Gorilla Glue Company (the adhesive maker) in 2017 and rebranded from 'Gorilla Glue' to 'GG' [1][2]. GG4 is the flagship and best-documented cut. Other numbered phenos — GG1, GG5, and so on — have been mentioned by the breeders, but public documentation of GG #14 as an official GG Strains release is thin to nonexistent Disputed.
This matters because in cannabis the same name can be attached to unrelated genetics by different sellers. Without a verified clone lineage or seed lot from a documented breeder, 'GG #14' should be treated as a marketing name, not a stable genetic identity.
Cultivation basics
Because there is no authoritative grower documentation specific to GG #14, the following reflects general reports for the GG line rather than verified GG #14 data Anecdote:
- Flowering: ~8–9 weeks indoors under 12/12.
- Structure: Medium height, moderate stretch, dense colas that can benefit from support and airflow to reduce mold risk.
- Environment: Prefers moderate humidity; late-flower buds are resin-heavy and prone to bud rot in humid rooms.
- Feeding: Typical high-THC hybrid nutrient loads; no unusual requirements reported.
- Difficulty: Moderate. Not a great pick for a first grow if you cannot control humidity, but not notoriously finicky.
If you are buying seeds or clones labeled GG #14, ask the vendor for the parent cross and, ideally, a COA (certificate of analysis) from a recent harvest of the same line.
Marketing vs. reality
What's marketing:
- Precise THC percentages attached to the name ('GG #14 = 24% THC'). Cultivar-level THC is not a fixed number; it varies by pheno, grow, and lab [3].
- Terpene charts copied from GG4 listings.
- Effect promises ('locks you to the couch,' 'crushes pain'). No clinical evidence supports strain-specific effect claims [4].
- The implication that GG #14 is a distinct, breeder-authenticated release. Public evidence for that is lacking Disputed.
What's plausible:
- It is a high-THC modern hybrid, likely resinous, likely in the GG stylistic family.
- Individual users report enjoyable, relaxing effects, which is consistent with many high-THC hybrids Anecdote.
Bottom line: enjoy it on its own merits, ignore the number, and judge the jar in front of you — not the name on the label.
Sources
- Reported Roberts, C. (2017). 'Gorilla Glue' Weed Is No More, Thanks to the Actual Gorilla Glue Company. Leafly News, October 2017.
- Reported Schroyer, J. (2017). Cannabis firm GG Strains settles trademark suit with Gorilla Glue Co., must change product names. Marijuana Business Daily.
- Peer-reviewed Jikomes, N., & Zoorob, M. (2018). The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific Reports, 8, 4519.
- Peer-reviewed National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press.
- Peer-reviewed Watts, S., McElroy, M., Migicovsky, Z., Maassen, H., van Velzen, R., & Myles, S. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7, 1330–1334.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Beta-Caryophyllene — A peppery sesquiterpene common in cannabis that binds the CB2 receptor, making it unusual...